Abstract:Whether humoral immunity plays a role in HPV type 6 or 11 virus-mediated Juvenile-onset Recurrent Respiratory Papillomatosis (JORRP) remains unknown. In the present study, serum total IgG level in 44 JORRP patients was significantly decreased compared with that in 40 healthy controls. Moreover, expanded CD3−CD19+ B cells with down-regulation of CD23, CD40, HLA-DR and up-regulation of CD86 expression were found in the peripheral blood of JORRP patients. Flow cytometry analysis of B-cell compartment showed that … Show more
“…In our previous studies, it has been revealed that children with JORRP exhibited a Th2-biased cytokine pro le [14]. Furthermore, we found that impaired T cell-dependent humoral immune response supported persistent HPV infection in JORRP [15]. These studies exposed the abnormal immune response of T cells to HPV in JORRP.…”
Background
Immunologic dysfunction is one of the most important mechanisms underlying the initiation and development of Juvenile-onset Recurrent Respiratory Papillomatosis (JORRP). The study aimed to explore whether HPV-specific T-cell response was impaired in JORRP patients.
Methods
A total of 46 JORRP patients and 93 age- and sex- matched healthy controls were enrolled. The plasma concentrations of various cytokines were measured using the Luminex. The cytokine mRNA profiles of PBMCs were quantified with the real-time PCR. The T-cell subsets, HPV-specific T-cell activation, proliferation, apoptosis and expression of replicative senescent T-cell markers CD57 were measured with the flow cytometry. The cytokine secretion of HPV-specific T cells was assessed by the ELISPOT.
Results
JORRP patients had a Th2-biased cytokine profile correlated with disease severity in the JORRP peripheral system. JORRP patients had an increased percentage of memory T cells and a reduced percentage of naive T cells in circulation. Upon HPV6/11 antigens stimulation, T cells from JORRP patients exhibited a greater activation profile as judged by a higher CD25 and CD69 expression. Of note, JORRP patients presented with a greater number of IL-10- and IL-4-secreting HPV6/11 antigen responding cells than that of IFN-γ and TNF-α secreting responders in the ELISPOT experiment. Furthermore, in response to HPV6/11 antigen stimulation, JORRP patients showed a reduced level of cell proliferation, an increased level of apoptosis and higher percentage of the differentiated T cells expressing the replicative senescent cell marker CD57.
Conclusions
Impaired HPV-specific T-cell responses could be partly responsible for JORRP development.
“…In our previous studies, it has been revealed that children with JORRP exhibited a Th2-biased cytokine pro le [14]. Furthermore, we found that impaired T cell-dependent humoral immune response supported persistent HPV infection in JORRP [15]. These studies exposed the abnormal immune response of T cells to HPV in JORRP.…”
Background
Immunologic dysfunction is one of the most important mechanisms underlying the initiation and development of Juvenile-onset Recurrent Respiratory Papillomatosis (JORRP). The study aimed to explore whether HPV-specific T-cell response was impaired in JORRP patients.
Methods
A total of 46 JORRP patients and 93 age- and sex- matched healthy controls were enrolled. The plasma concentrations of various cytokines were measured using the Luminex. The cytokine mRNA profiles of PBMCs were quantified with the real-time PCR. The T-cell subsets, HPV-specific T-cell activation, proliferation, apoptosis and expression of replicative senescent T-cell markers CD57 were measured with the flow cytometry. The cytokine secretion of HPV-specific T cells was assessed by the ELISPOT.
Results
JORRP patients had a Th2-biased cytokine profile correlated with disease severity in the JORRP peripheral system. JORRP patients had an increased percentage of memory T cells and a reduced percentage of naive T cells in circulation. Upon HPV6/11 antigens stimulation, T cells from JORRP patients exhibited a greater activation profile as judged by a higher CD25 and CD69 expression. Of note, JORRP patients presented with a greater number of IL-10- and IL-4-secreting HPV6/11 antigen responding cells than that of IFN-γ and TNF-α secreting responders in the ELISPOT experiment. Furthermore, in response to HPV6/11 antigen stimulation, JORRP patients showed a reduced level of cell proliferation, an increased level of apoptosis and higher percentage of the differentiated T cells expressing the replicative senescent cell marker CD57.
Conclusions
Impaired HPV-specific T-cell responses could be partly responsible for JORRP development.
“…Since introduction of HPV vaccination (Gardasil ® ) in Australia in 2007, there has been a marked reduction in clinic presentations for genital warts by Aboriginal and Torres Strait Islander Australians aged 21–30 years, 19 but not in older age groups. Surveillance studies continue to monitor new cases of HPV disease and associated types; however, HPV‐related disease remains a concern as does its role in humoral and innate immune impairment 3 . The question of whether HPV plays a role in the very high rates of respiratory infection with immune impairment 20 in Aboriginal infants remains incompletely addressed; however, our results suggest that vertical HPV transmission is an unlikely contributor.…”
Section: Discussionmentioning
confidence: 86%
“…In infants, the most commonly known manifestation of HPV is respiratory papillomatosis where stridor is often the presenting symptom. However, HPV infection is also associated with impaired humoral and innate immune responses that predispose the child to increased risk of infection 3 . Children may thus also present with recurrent pneumonia, bronchiectasis, and declining pulmonary status 2 .…”
Maternal urogenital human papillomavirus (HPV) infection may place neonates at risk of HPV acquisition and subsequently lower respiratory infections as HPV can influence development of immunity. The respiratory HPV prevalence is not known in remote‐dwelling Aboriginal infants, who are at high risk of respiratory infection and where the population prevalence of urogenital HPV in women is high. These data are necessary to inform HPV vaccination regimens. A retrospective analysis using PCR specific for HPV was performed on 64 stored nasopharyngeal swabs from remote‐dwelling Aboriginal infants < 6 months of age, with and without hospitalised pneumonia. HPV DNA was not detected in any specimen. Despite the negative result, we cannot exclude a role for HPV in respiratory infections affecting infants in this population; however, our data do not support HPV as an important contributor to acute respiratory infection in remote‐dwelling Aboriginal children.
“…T-cell surface marker staining and intracellular cytokine staining for flow cytometry analysis were performed as described previously. 23 , 24 In brief, freshly isolated PBMCs (Ficoll-Hypaque density gradients centrifugation) from fresh whole blood were stimulated with Phorbol-12-myristate-13-acetate (PMA, 50 ng/mL; Sigma-Aldrich) and ionomycin (1 μg/mL; Sangon Biotech) for 4 h. Cell surface staining was performed for 30 min at room temperature followed by fixation and permeabilization using an intracellular staining assay (BD Biosciences) according to the manufacturer's instructions. Cells were then stained with PE-anti-TNFα (Mouse IgG1, clone MAb11), APC-anti-IFNγ (Mouse IgG1, clone B27), or corresponding isotype control antibodies (all from BD Biosciences) at 4 °C for 30 min.…”
Wilms tumor (WT) is the most common renal cancer and the most prevalent abdominal cancer in children. Children with recurrent or progressive forms of WT could benefit from novel immune-targeted approaches. While the immune status of these patients, especially the immunosuppression of peripheral T cells, was rarely reported. The present study enrolled a consecutive series of 14 Chinese WT children and 14 age- and gender-matched healthy controls. We demonstrated that plasma extracellular vesicular (EV) PD-L1 levels significantly increased in WT patients than in healthy controls. EV PD-L1 significantly inhibited the activation of human CD8+ T cells by down-regulating the cell surface CD69 expression and the intracellular IFNγ and TNFα production in vitro. In peripheral CD8+ T cells of WT patients, the intracellular IFNγ and TNFα production significantly decreased than healthy controls. The level of plasma EV PD-L1 significantly correlated with the intracellular TNFα production in peripheral CD8+ T cells of WT patients. In conclusion, the significantly increased plasma EV PD-L1 in WT patients contributed to the immunosuppression of peripheral CD8+ T cells. Monitoring the level of plasma EV PD-L1 will be helpful for the selection of immune-targeted therapies for WT patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.